OBIO

Orchestra BioMed Holdings, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$6.15

Price (1 Year)

$6.15 $3.49

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %16.5 / %30
Non-compliant assets / Total market cap %42.5 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease.

Website

Analysis (Turkish): OBIO Hissesi Caiz mi, Helal mi? Orchestra BioMed Holdings, Inc. Katılım Analizi